Table 1.
Pathological abnormalities of H11Met/+/PtenL/L:PB-Cre4 and PtenL/L:PB-Cre4 mice
| Genotype | <4 months | 4–10 months | >10 months |
|---|---|---|---|
| PtenL/L:PB-Cre4 | 4 of 4 LGPIN | 6 of 6 multifocal HGPIN | 6 of 8 intracystic carcinoma |
| 2 of 4 multifocal HGPIN | 2 of 6 intracystic carcinoma | 4 of 8 adenocarcinoma | |
| 3 of 8 invasive carcinoma | |||
| 1 of 8 invasive carcinoma with metastasisa | |||
| H11Met/+/PtenL/L:PB-Cre4 | 5 of 5 multifocal HGPIN | 5 of 5 multifocal HGPIN | 7 of 8 adenocarcinoma, 6 of 8 invasive carcinoma |
| 1 of 5 intracystic carcinoma | 6 of 8 invasive carcinoma | ||
| 2 of 5 adenocarcinomas | 5 of 8 invasive carcinoma with EMT | ||
| 1 of 5 invasive carcinoma | 5 of 8 invasive carcinoma with metastasisb |
a Metastatic sites include lymph node and lung tissues.
b Metastatic sites include lymph node, lung, and pancreas tissues.